{
  "id": "fdeaee6b812e1c98",
  "title": "US FDA Declines to Approve Outlook Eye Disease Drug for Second Time in 2025",
  "description": "20260102T181500Z",
  "content": "",
  "source": "medscape.com",
  "source_url": "https://www.medscape.com/s/viewarticle/us-fda-declines-approve-outlooks-eye-disease-drug-second-2025a10010uf",
  "published_at": "20260102T181500Z",
  "fetched_at": "2026-01-03T00:22:18.884957+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.medscape.com/s/viewarticle/us-fda-declines-approve-outlooks-eye-disease-drug-second-2025a10010uf",
    "url_mobile": "",
    "title": "US FDA Declines to Approve Outlook Eye Disease Drug for Second Time in 2025",
    "seendate": "20260102T181500Z",
    "socialimage": "https://img.medscape.com/thumbnail_library/Social_Facebook_806x806.jpg",
    "domain": "medscape.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}